Fixation of RTX to CD20, density of CD20 molecules, GM1 and SM levels, complement inhibitor proteins CD55, CD59 and Factor H were evaluated in CLL cells in the two groups of patients. The gene discussed is CD59; the disease is B-cell chronic lymphocytic leukemia.